JF
PTCT icon

Jump Financial’s PTC Therapeutics PTCT Stock Holding History

Jump Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
+33,374
New +$2.41M 0.02% 762
2025
Q3 		– Sell
-51,606
Closed -$2.52M – 2136
2025
Q2 		$2.52M Buy
+51,606
New +$2.45M 0.03% 641
2025
Q1 		– Sell
-62,809
Closed -$2.84M – 1935
2024
Q4 		$2.84M Buy
+62,809
New +$2.69M 0.06% 411
2024
Q3 		– Sell
-73,088
Closed -$2.24M – 2030
2024
Q2 		$2.24M Buy
73,088
+35,141
+93% +$1.14M 0.04% 501
2024
Q1 		$1.1M Buy
37,947
+11,691
+45% +$327K 0.03% 751
2023
Q4 		$724K Buy
26,256
+10,846
+70% +$248K 0.02% 880
2023
Q3 		$345K Buy
15,410
+9,494
+160% +$353K 0.01% 1226
2023
Q2 		$241K Buy
+5,916
New +$289K 0.01% 1426
2022
Q4 		– Sell
-67,762
Closed -$3.4M – 1947
2022
Q3 		$3.4M Sell
67,762
-38
-0.1% -$1.86K 0.13% 226
2022
Q2 		$2.72M Buy
67,800
+60,200
+792% +$2.11M 0.12% 236
2022
Q1 		$284K Buy
+7,600
New +$293K 0.01% 1094

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jump Financial's PTCT Position: Q2 2026 in Review

Jump Financial opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 33,374 shares worth $2.72M. The stake represents 0.02% of the portfolio and ranks #762 among its holdings. This is a return to the name: Jump Financial previously reported a position in PTCT as recently as Q2 2025.

Jump Financial first reported a position in PTCT in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.4M in Q3 2022. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Jump Financial held 33,374 shares of PTC Therapeutics worth $2.72M as of Q2 2026.
  • PTC Therapeutics was a new Jump Financial position in Q2 2026.
  • PTC Therapeutics made up 0.02% of Jump Financial's portfolio in Q2 2026, its #762 holding.
  • Jump Financial first reported a position in PTC Therapeutics in Q1 2022 and has held it in 11 quarters since.
  • Jump Financial's PTC Therapeutics position peaked at $3.4M in Q3 2022.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.